4-((1-(Tert-butoxycarbonyl)piperidin-4-yl)oxy)benzoic acid, 95+%, 1g

(T-4)-[[2,2'-[(1S,2S)-1,2-Cyclohexanediylbis[(nitrilo-κN)methylidyne]]bis[4,6-bis(1,1-dimethylethyl)phenolato-κO]](2-)]zinc, 95%, 25g

(R)-4-(4,6-Dichloro-1,3,5-triazin-2-yl)-3-methylmorpholine, 98%, 250mg

trans-4-Acetoxycinnamic Acid>98.0%(GC)(T)5g

Tetrabutylammonium Tetrakis(trifluoromethyl)cuprate(III)>98.0%(T)200mg

2-phenyl-5(4H)-Oxazolone, 95.0%, 5g

1-[1-(3-Fluorophenyl)-1H-pyrazol-5-yl]methanamine hydrochloride, 1g

4,6-Dichloro-2-cyclopropylpyrimidine, 95.0%, 1g

2-Amino-4,5-difluorobenzamide, 95%, 100mg

(S)-Tol-SDP, 97%, 25mg

Tert-butyl 5-iodo-1H-indazole-1-carboxylate, 98%, 1g

tert-Butyl (2-((4-fluorobenzyl)amino)ethyl)carbamate, 95.0%, 250mg

2-(3-(Trifluoromethyl)phenyl)morpholine hydrochloride, 95.0%, 1g